Risk factors and outcomes of carbapenem-resistant Klebsiella pneumoniae infections
In the nosocomial setting, antimicrobial-resistant Enterobacteriaceae are a growing challenge, and alarming trends in resistance are currently reported all over the world. Isolates of Enterobacteriaceae producing ampC <span>β</span>-lactamases and extended spectrum <span>β</span...
Main Authors: | Eleonora Pistella, Claudio Santini |
---|---|
Format: | Article |
Language: | English |
Published: |
PAGEPress Publications
2016-12-01
|
Series: | Italian Journal of Medicine |
Subjects: | |
Online Access: | http://www.italjmed.org/index.php/ijm/article/view/798 |
Similar Items
-
Ceftazidime-avibactam in the treatment of infections from carbapenem-resistant Klebsiella pneumoniae
by: Jie Gu, et al.
Published: (2021-09-01) -
Deaths Attributable to Carbapenem-Resistant Enterobacteriaceae Infections
by: Matthew E. Falagas, et al.
Published: (2014-07-01) -
IN VITRO EFFICACY OF CICLOPIROX AGAINST CARBAPENEM RESISTANT ENTEROBACTERIACEAE
by: Maliha Ansari, et al.
Published: (2021-06-01) -
Epidemiological study of carbapenem-resistant Klebsiella pneumoniae
by: Lin Di, et al.
Published: (2018-10-01) -
Risk Factors for and Clinical Outcomes of Carbapenem-Resistant Klebsiella pneumoniae Nosocomial Infections: A Retrospective Study in a Tertiary Hospital in Beijing, China
by: Zhang H, et al.
Published: (2021-04-01)